CHAPTER 1 INTRODUCTION 1 OBJECTIVES: • • • To observe the practices adopted in each department. To understand the management activities performed in each department.…
1. Regulatory and QA Considerations for Drug Product Development Louise Johnson, M.S. Chinese American Biopharmaceutical Society Meeting June 5, 2010 2. Core Principles Patient…
1. NPS Pharmaceuticals:Pioneering and delivering therapies thattransform the lives of patients with rarediseases worldwideJune 2013 2. 2Safe harbor statementStatements made…
1. EXECUTIVE SUMMARY PRESENTATION Victor Esan Proposal for a Vein Clinic as another service line opportunity for a cardiology practice 2. What is done in a Vein Clinic ?…
Slide 1 ANNUAL GENERAL MEETING 30 th September 2010 Slide 2 AGENDA Welcome – Sir Philip Hunter, Chairman Formal presentation of the Trust Accounts Colin Groom – Deputy…